retatrutide constipation UK: New Triple-Agonist Weight Loss Injection Explained Retatrutide and Hair Loss -

Long-term adherence is essential to realizing the full therapeutic potential of GLP-1s, yet behavioral factors (such as reaching personal weight goals or perceived social stigma) and systemic issues (like high out-of-pocket costs and fragmented care) disproportionately affect obesity patients

But you might wonder where Mounjaro fits into this landscape

Is the abdomen the best injection site for GLP-1 medications

It can be prescribed to adults with obesity who have a body mass index (BMI) of 30 or above, or who are overweight with a BMI between 27 and 30 and at least one weight-related comorbidity, and should be used alongside a reduced-calorie diet and increased physical activity